(4S,4'S)-2,2'-(2,3-Dihydro-1H-indene-2,2-diyl)bis(4-isopropyl-4,5-dihydrooxazole)
97%
- Product Code: 237979
CAS:
2757082-01-0
| Molecular Weight: | 340.46 g./mol | Molecular Formula: | C₂₁H₂₈N₂O₂ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD32899509 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8°C, sealed, dry, inert gas |
Product Description:
Used as a chiral ligand in asymmetric catalysis, particularly in enantioselective transformations such as hydrogenation and carbon-carbon bond-forming reactions. Its rigid indene backbone and chiral oxazoline rings enhance stereocontrol, making it valuable in the synthesis of optically active pharmaceuticals and fine chemicals. Effective with transition metals like rhodium and iridium, it helps achieve high enantiomeric excess in catalytic processes.
Sizes / Availability / Pricing:
| Size | Availability | Price | Quantity |
|---|---|---|---|
| 0.100 | 10-20 days | $214.55 |
+
-
|
| 0.250 | 10-20 days | $319.92 |
+
-
|
| 1.000 | 10-20 days | $1,038.36 |
+
-
|
(4S,4'S)-2,2'-(2,3-Dihydro-1H-indene-2,2-diyl)bis(4-isopropyl-4,5-dihydrooxazole)
Used as a chiral ligand in asymmetric catalysis, particularly in enantioselective transformations such as hydrogenation and carbon-carbon bond-forming reactions. Its rigid indene backbone and chiral oxazoline rings enhance stereocontrol, making it valuable in the synthesis of optically active pharmaceuticals and fine chemicals. Effective with transition metals like rhodium and iridium, it helps achieve high enantiomeric excess in catalytic processes.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
$0.00
$0.00
Total :